Differential serum protein markers and the clinical severity of asthma

Journal of Asthma and Allergy

Volumn , Issue 7, 2014, Pages 67-75

  Meyer, Norbert ^a,b   Nuss, Sarah Janine ^a   Rothe, Thomas ^a   Siebenhüner, Alexander ^a   Akdis, Cezmi A ^b   Menz, Günter ^a  

^a Hochgebirgsklinik Davos ^*  (Switzerland)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Asthma; Cluster; Phenotype; Serum cytokines

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 8; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; VALIDITY;

EID: 84903584307     PISSN: 11786965     EISSN: None     Source Type: Journal    
DOI: 10.2147/JAA.S53920     Document Type: Article

References (26)

1. Lötvall J, Akdis CA, Bacharier LB, etal. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355-360.
2. Kim HY, DeKruyff RH, Umetsu DT. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol. 2010;11(7):577-584.
3. Robinson DS, Hamid Q, Ying S, etal. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992;326(5):298-304.
4. Walker C, Bauer W, Braun RK, etal. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med. 1994;150(4): 1038-1048.
5. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol. 2009;123(4): 735-746; quiz 747-748.
6. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA. Role of Treg in immune regulation of allergic diseases. Eur J Immunol. 2010;40(5):1232-1240.
7. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol. 2007;293(2):L505-L515.
8. Hellings PW, Kasran A, Liu Z, etal. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol. 2003;28(1):42-50.
9. Meyer N, Zimmermann M, Bürgler S, etal. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol. 2010;125(4):858-865. e10.
10. Kim JH, Kim JE, Choi GS, Him HY, Ye YM, Park HS. Serum cytokines markers in toluene diisocyanate-induced asthma. Respir Med. 2011;105(7):1091-1094.
11. Agache I, Ciobanu C, Agache C, Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med. 2010;104(8): 1131-1137.
12. Meyer N, Christoph J, Makrinioti H, etal. Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol. 2012;129(4): 964-973. e7.
13. Pukelsheim K, Stoeger T, Kutschke D, Ganguly K, Wjst M. Cytokine profiles in asthma families depend on age and phenotype. PLoS One. 2010;5(12):e14299.
14. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-907.
15. Balzar S, Strand M, Nakano T, Wenzel SE. Subtle immunodeficiency in severe asthma: IgA and IgG2 correlate with lung function and symptoms. Int Arch Allergy Immunol. 2006;140(2):96-102.
16. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372(9643):1107-1119.
17. Burgler S, Ouaked N, Bassin C, etal. Differentiation and functional analysis of human T(H)17cells. J Allergy Clin Immunol. 2009;123(3):588-595,595. e1-e7.
18. Jones CE, Chan K. Interleukin-17stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol. 2002;26(6):748-753.
19. Wang YH, Voo KS, Liu B, etal. A novel subset of CD4(+) T(H)2memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med. 2010;207(11):2479-2491.
20. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol. 2001;107(6):1034-1038.
21. Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy. 2010;65(8):946-958.
22. Green RH, Brightling CE, McKenna S, etal. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360(9347):1715-1721.
23. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54-61.
24. Malinovschi A, Pizzimenti S, Sciascia S, Heffler E, Badiu I, Rolla G. Exhaled breath condensate nitrates, but not nitrites or FENO, relate to asthma control. Respir Med. 2011;105(7):1007-1013.
25. Kostikas K, Papaioannou AI, Tanou K, etal. Exhaled NO and exhaled breath condensate pH in the evaluation of asthma control. Respir Med. 2011;105(4):526-532.
26. Tillie-Leblond I, de Blic J, Jaubert F, Wallaert B, Scheinmann P, Gosset P. Airway remodeling is correlated with obstruction in children with severe asthma. Allergy. 2008;63(5):533-541.